von Tresckow, Julia http://orcid.org/0000-0001-5873-4603
Heyl, Nikola
Robrecht, Sandra
Giza, Adam
Aldaoud, Ali
Schlag, Rudolf
Klausmann, Martine
Linde, Hartmut
Stein, Wolfgang
Schwarzer, Andreas
Fischer, Kirsten
Cramer, Paula
Eichhorst, Barbara
Hallek, Michael
Fink, Anna Maria
Funding for this research was provided by:
Universitätsklinikum Essen
Article History
Received: 26 January 2023
Accepted: 7 June 2023
First Online: 26 June 2023
Declarations
:
: The registry study of the German CLL study group was approved by all involved Ethic committees according to the declaration of Helsinki and German physicians’ professional regulation.
: All patients provided informed consent.
: Julia von Tresckow: reports travel support by AbbVie, AstraZeneca, Beigene, Janssen, Lilly and Roche and is an advisor or consultant for AbbVie, Amgen, AstraZeneca, Beigene, Janssen and Roche; has received honoraria from AbbVie, AstraZeneca, Beigene, Janssen, Lilly and Roche.Nikola Heyl, Sandra Robrecht, Adam Giza, Ali Aldaoud and Rudolf Schlag: have nothing to disclose.Martine Klausmann: reports consultancy for Biotest and has received honoraria by BMS, Novartis, Abvie, Biotest, Octapharm and Geron.Hartmut Linde: has received honoraria by Mundipharma and is an advisor for Amgen, Novartis and Mundipharma and reports travel support by Servier, Novartis, Janssen, Abbvie, BMS.Wolfgang Stein and Andreas Schwarzer: have nothing to disclose.Kirsten Fischer: reports honoraria by AbbVie and Roche and is an advisor for AstraZeneca.Paula Cramer: reports research funding by Acerta, AstraZeneca, Beigene, F. Hoffmann-LaRoche, Gilead, Janssen-Cilag and Novartis and has received honoraria from AbbVie, AstraZeneca, F. Hoffmann-LaRoche and Janssen-Cilag; is an advisor for AbbVie, AstraZeneca and BeiGene and received travel support by AbbVie, AstraZeneca, BeiGene, and F. Hoffmann LaRoche.Barbara Eichhorst is an advisor or consultant for Janssen, Roche, Novartis, AbbVie, Gilead, Celgene, AstraZeneca, MSD and Miltenyi and received honoraria from Janssen, Gilead, Roche, AbbVie, Novartis, Celgene, AstraZeneca, BeiGene and MSD; reports research funding by Janssen, Gilead, Roche, AbbVie, BeiGene and Astra Zeneca.Michael Hallek: is an advisor or consultant for Roche, Gilead, Janssen, Bristol Myers Squibb, AbbVie and AstraZeneca and reports honoraria from Roche, Gilead, Janssen, Bristol Myers Squibb, AbbVie and AstraZeneca. Anna Maria Fink: reports research funding by AstraZeneca and Celgene and travel support by AbbVie.